Relay Therapeutics
Relay Therapeutics
Clinical-stage precision medicine company using protein motion insights for drug discovery.
About
Relay Therapeutics is a clinical-stage precision medicine company that integrates computational and experimental technologies to understand protein motion and transform drug discovery. Their proprietary Dynamo Platform visualizes how proteins move, enabling precise drug design for targets previously considered intractable. The company is advancing a pipeline of medicine candidates for precision oncology and genetic diseases.
Key facts
- Website
- relaytx.com
- Headquarters
- Cambridge, United States
- Founded
- 2015
- Total funding
- $825M (Public Offering)
- Valuation
- Private
- Business model
- B2B
- Tags
- BiotechDrug DiscoveryPrecision MedicineOncologyGenetic Disease
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 20 May 2026 | Public Offering | $275M | - |
| 8 Jan 2024 | Private Placement | $30M | - |
| 20 Dec 2018 | Series C | $400M | - |
| 14 Dec 2017 | Series B | $63M | - |
| 14 Sept 2016 | Series A | $57M | Third Rock Ventures |
Tech stack
Detected on relaytx.com, last scanned 17 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- LinkedIn Insight Tag
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Proofpoint
- Cookie consent
- OneTrust
Add first review
Frequently asked
How much funding has Relay Therapeutics raised?
Relay Therapeutics has raised a total of $825M in funding. The most recent round on record is Public Offering.